Bryan Davis
CEO of BeneDoc and AI Architect for Enterprise
Actions
Bryan Davis is a technology executive and product leader specializing in the application of ML and AI to high-stakes work. He is a prominent figure in applied AI for enterprise, having worked across and founded companies in the legal tech, healthtech, and regulatory tech spaces. He was the cofounder and CTO of the venture-backed legal-tech company Centari, widely adopted by the world's largest law firms, and is most recently the founder and CEO of BeneDoc. His prior background includes work at Indeed, Meta, and Nextdoor where he managed a team through the company's IPO.
Bryan’s career is deeply rooted in the South: he’s a native North Carolinian, holds two degrees from the University of North Carolina at Chapel Hill, lived and worked for five years in Texas, and has become a prominent member of the Triangle’s entrepreneurship community since his return from San Francisco.
Inside the Sale, Inside the Build: AI for Enterprise
When you’re pitching an AmLaw 100 partner or a Medical Device CTO, they don’t care about your vision—they care about their liability. This session takes technical founders backstage into the high-stakes closing rooms and the engineering labs where Bryan Davis built trust with the world's most risk-averse buyers.
We’ll walk through the checklist of building AI-native solutions for high-stakes industries: what their decision-makers look for when they’re conducting due diligence and how to convince them. Bryan will share stories directly from his time working as both an outsider and an insider at the world’s largest law firms, universities, and healthtech companies, revealing the path to move from a demo to 99.9% verifiability.
Engineering Verifiable AI Applications
In sectors like Law and Life Sciences, the gap between a "wow" demo and a commercial product is measured in liability. For a Medical Device CTO or an AmLaw 100 Partner, "vision" is secondary to verifiability. This hands-on workshop moves past the chatbot era and into the engineering lab, guiding you through the end-to-end construction of a grounded AI application designed for 99.9% accuracy and enterprise-grade due diligence.
The Workshop Modules
Phase 1: The Traceability Skeleton: Engineering the core architecture where every AI claim is mapped to its specific source (clinical papers, case law, or internal guidelines) for sub-two-second human verification.
Phase 2: Context Translation & Knowledge Trees: Moving beyond simple RAG. We will build logic paths that translate unstructured domain expertise into structured knowledge trees and agentic search patterns.
Phase 3: The Automated Quality Referee: Implementing "LLM-as-a-judge" frameworks and custom evaluation sets. Learn to replace subjective "vibes" with hard validation metrics that prove reliability to risk-averse buyers.
Phase 4: Deployment & Sovereignty: Navigating the technical hurdles of high-stakes environments—configuring VPC-ready stacks and interoperable data layers to ensure IP protection and avoid vendor lock-in.
Practical Outcomes
The Built-to-Vette Pipeline: A repeatable workflow for moving from raw research to a production-ready model that survives a "Red Team" audit.
Hybrid Logic Models: Mastering the decision-making process for when to use rigid, deterministic data paths versus flexible, agentic feedback loops.
The Enterprise Due Diligence Toolkit: A technical checklist of the verification steps, security standards, and accuracy proofs required to close enterprise deals.
Traversing the Valley of Death: Staying Default-Alive in MedTech
Ninety percent of MedTech startups fail within five years. They don't die because the science is wrong or the founders lack vision; they die in the gap between a "brilliant prototype" and a "commercializable product." This is the MedTech Valley of Death—a six-year, $18-million-dollar structural chasm where speed-of-light innovation meets the speed-of-paper bureaucracy.
In this session, Bryan Davis (Founder of BeneDoc) deconstructs the specific system failures that kill ambitious startups and explores how a new era of "insider" engineering is finally building a bridge across the chasm.
The Anatomy of the Chasm
The Lab-to-Product Trap: Why a "working" prototype is only 10% of the journey. We’ll discuss the brutal transition from the controlled environment of the lab to the chaotic reality of the clinic, where edge cases, legacy integrations, and user friction become existential threats.
The Paperwork Tax: Why moving from "Concept to Care" requires 1,000+ page submissions and years of rote, manual documentation that drains capital before a single patient is treated.
The Validation Wall: Procurement and regulatory bodies don’t buy "vibes" or "demos." We’ll look at the "Translation Assembly Line"—the process of turning messy clinical breakthroughs into structured, vette-able logic trees that satisfy institutional risk.
The Monetization Gap: The final, fatal hurdle. We’ll explore why startups get stuck providing free utilities to cash-strapped teams, failing to convert ground-floor credibility into the high-ticket enterprise contracts needed to fuel the $18M regulatory climb.
The Survival Playbook
Engineering for Liability: Moving from manual to automated verification, where every system decision is mapped to a primary clinical or regulatory source in under two seconds. If it isn't traceable, it isn't commercial.
Leaning into Partnerships: Stop building in a vacuum. Learn how to secure design partnerships early to solve for specific enterprise stacks, ensuring you’re building a bridge to a buyer, not a dead end.
Monetizing Early: How to move from "free utility" to "essential infrastructure." We’ll discuss strategies for capturing revenue early in the lifecycle to prove market pull and fund the crossing of the valley.
Please note that Sessionize is not responsible for the accuracy or validity of the data provided by speakers. If you suspect this profile to be fake or spam, please let us know.
Jump to top